Navigation Links
NeurogesX to Present at Roth 2008 OC Growth Stock Conference
Date:2/19/2008

SAN MATEO, Calif., Feb. 19 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing novel pain management therapies, announced today that it is scheduled to present at the Roth Capital Partners 20th Annual OC Growth Stock Conference in Laguna Niguel, CA on February 20, 2008. Anthony DiTonno, President and Chief Executive Officer, will be presenting and Stephen Ghiglieri, Chief Financial Officer, will be available to respond to questions during the break out session.

Event: Roth Capital 20th Annual OC Growth Stock Conference

Date: Wednesday, February 20, 2008

Time: 2:00 p.m. Pacific Time

Place: Ritz Carlton, Laguna Niguel, CA (Salon 3)

An audio Web cast of the Company's presentation will be available by going to the investor relations section of NeurogesX' Web site at http://www.neurogesx.com. A replay of the presentation will be available for 15 days.

About NeurogesX, Inc.

NeurogesX (Nasdaq: NGSX) is a biopharmaceutical company focused on developing novel pain management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy. NeurogesX' late stage product portfolio is led by its product candidate NGX-4010, a dermal patch designed to manage pain associated with peripheral neuropathic pain conditions, that the company
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. NeurogesX to Present at the 10th Annual BIO CEO & Investor Conference
2. NeurogesX Closes $25 Million Private Placement
3. NeurogesX, Inc. Announces $25 Million Private Placement
4. NeurogesX to Present at Lazard Capital Markets Healthcare Conference
5. NeurogesX to Present at CIBC World Markets 18th Annual Healthcare Conference and Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
6. NeurogesX Expands Senior Management Team
7. NeurogesX to Present at UBS 2007 Global Life Sciences Conference
8. NeurogesX Appoints New Director to the Board
9. NeurogesX to Present at BioCenturys NewsMakers in the Biotech Industry Conference
10. AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
11. AspenBio Pharma to Present at the Roth Capital Partners 20th Annual Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...Newswire/ -- BioTrends Research Group, Inc.,releas...M) publication, a,syndicated report offering compr...ia and bone and mineral metabolism in Chronic Kidn... information from 182 US,Nephrologists -- data wer...ne 2008., In the renal anemia market, while the u...
(Date:7/25/2008)...X, CALGARY, July 25 / Resv...X:RVX) is pleased to announce effective,immediatel...irectors. On,the subject of her appointment Jan Gr...xciting opportunity for me. The Company has done a...linical trials. I expect the next,foreseeable futu...
(Date:7/25/2008)...swire-FirstCall/ -- Caraco Pharmaceutical,Laborato...first quarter of,Fiscal 2009, ended June 30, 2008,...or the corresponding period of Fiscal 2008. This r...er of Fiscal 2008. Pre-tax income grew,to $14.6 mi...ared to a,pre-tax income of $9.6 million during th...
(Date:7/25/2008)...25 /- REvolution Computing will,lead ...R product at the,upcoming BioC 2008 conference in ... REvolution Computing Director of Community, Dr. D... Training Manager, and Martin Morgan of,the Fred H...ting,s BioC lab,will introduce participants to the...
Breaking Biology Technology:BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 2BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 3Jan Gray Joins Resverlogix Board of Directors 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 3Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 4Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 5Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 6Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 7REvolution Computing Offers Hands-On Tutorial of NWS Parallel Computing Environment at BioC 2008 2
...re Wisconsin companies are expected to pitch their...re Forum . , ,Eight companies from Wisconsin are n...which this year will be in Minneapolis. , ,The fo... life sciences associations and the Biotechnology ...and medical device product and platform companies....
..., Wis. -- GenTel BioSurfaces, Inc., of Madison ...zymatic labeling technology for biomolecules and l...nTel will market and sell the Universal Linkage Sy...BV of Amsterdam, under its brand name Pandeia in ...e on GenTel,s PATH protein microarray technology p...
..., Wis. -- A report is due this fall that will he...ine whether and how to proceed with an IT project ...on was spent working to implement it over a five-y...ht with problems, including a lack of good project...fits Systems project (ABPS) for the UW System was ...
..., Wis. - Alfalight, Inc., a manufacturer of diode...tions markets worldwide, has received $7 million i...sday. , ,The financing package was led by GF Priva...t,s major previous investors. Those include ARCH ...F Ventures, CenterPoint Ventures, Venture Investor...
Other Biology Technology:Three more Wisconsin firms to present at venture forum 2UW working to salvage multi-million HR software project 2UW working to salvage multi-million HR software project 3UW working to salvage multi-million HR software project 4UW working to salvage multi-million HR software project 5Alfalight receives $7 million in expansion funding 2
(Date:7/25/2008)...en born with hydrocephalus, or "water on the brain...ay from the brain to reduce harmful pressure. , ... infection in children is very high for a variety ...gh another surgery to replace the shunt, bringing ...eurological complications and an increased risk of...
(Date:7/25/2008)...d ,green, can potentially contain a naturally occu...risk to public health according to a review paper ...rnal of the Science of Food and Agriculture (JSFA... the ,green, affected area is enough to eliminate ... also suggests that the levels of GA in potatoes c...
(Date:7/24/2008)...k up plants just as they do human athletes, but th...s to boost growth and development in plant cells i...lls. A new study by plant biologists at the Carneg... called proteomics to identify key links in the st...nt hormones activate genes could lead not only to ...
(Date:7/24/2008)...rus called cytomegalovirus (CMV), which most commo..., can also affect hospital intensive-care patients... Washington researchers have found. CMV infection ...ive-care unit (ICU) stays independent of other cau... JAMA , the Journal of the American Medical Assoc...
Breaking Biology News(10 mins):Antimicrobial sutures reduce infections in brain shunt surgery, study finds 2Plant steroids offer new paradigm for how hormones work 2Plant steroids offer new paradigm for how hormones work 3CMV infections affect more than just patients with compromised immune systems, researchers find 2TAX ALERT 3A Deductions for Long Term Care Insurance Premiums 14532 1TAX ALERT 3A Deductions for Long Term Care Insurance Premiums 14532 2Ingenuity Systems Extends Enterprise Level Software Agreement With GlaxoSmithKline 4029 1Ingenuity Systems Extends Enterprise Level Software Agreement With GlaxoSmithKline 4029 2Cell Therapeutics Inc 28CTI 29 Invest Northwest Presentation to be Webcast 4026 1Reducing HD risk naturally post menopause 14530 1Reducing HD risk naturally post menopause 14530 2
...hronic smoking affects nerve cells and alters the ...h presented today at the annual meeting of the Rad...s is the first imaging study to focus on the relat...endence," said Okan Gür, M.D., from the Department.... , Dr. Gür and colleagues used proton magneti...
...esearchers at the University of Southern Californi...om an enzyme family that, through its ability to m.... , Reporting in the Dec. 24 online edition of Na...e "unusual" crystal structure of the Apo2 enzyme. ... first mechanistic analysis of any of the APOBEC e...
...nvestigators at St. Jude Children,s Research Hospi... from certain pneumonia-causing bacteria can cause...ow antibiotic therapy can contribute to this damag...d by dying bacteria. The team also demonstrated in... , The study shows that pieces of cell walls from ...
... biologist at Washington University in St. Louis a... mammalian brain cells that keeps cells in synchro...rmone secretion and loco motor behaviors are coord... Ph.D., Washington University associate professor ...., a graduate student in Herzog’s lab who is now a...
Other Biology News:Smoking changes brain chemistry 2USC team reveals structure of APOBEC family protein 2Cell wall of pneumonia bacteria can cause brain and heart damage 2Cell wall of pneumonia bacteria can cause brain and heart damage 3Protein shown to rally biological clock 2
...1301 mutS are mismatch repair minus strains of E. ...newly synthesized unmethylated strand (1), leading...pful in such systems as the GeneEditor and Altered... 71-18 mutS are recA+, therefore inserts containin...
Polaroid black & white positive, 3 x 4 inch pack film, ISO 3000/ 36 ASA DIN (20 expsures). For use in the Polaroid Direct Copy Camera (PHC34).
Request Info
SHEEP ANTI ECHIS OCCELATUS (VENOM)
Biology Products: